Several years to 20s and i mean Several If we are lucky.
discodave1, if you truly think (if we are lucky) this will be a "several years" operation till we hit the $20's then I'm sure you may be selling much of your shares? ---------------------------------------------------------------
I will totally disagree though with that statement of Peregrine going to take several years to reach the $20's pps.
The buzz word all through cancer trials will continue to be "Immuno-Therapy" and I believe Peregrine is in the midst of building a very strong case that PS Targeting drugs such as Bavituximab will be "REQUIRED" to have a true "immuno-therapy" effect on fighting back cancer.
Everything is lining up quite well for Peregrine, since its Big Pharma giants like Roche-Genentech, Merck and BMS that are trying to pave the way into "downstream" agents such as PD-1, PD-L1 and CTLA-4 and I have a little hunch that the rest of Big Pharma is not going to sit back and watch these guys take the lead.
Fortunately for Peregrine, there are many options. Partner with Big Pharma... partner with Med size Pharma players... or simply set up their own "string of pearls" collaborations that will go unmatched by any other Big Pharma out there and license away what everyone needs to treat patients with cancer in the longterm = PS targeting drugs such as Bavituximab.
So taking several years to reach the $20's ? I'd say its more like some Big Pharma out there will want that jump start and take the early lead on immuno-therapy and they will only get there with making PS targeting the heart of the operation.
The heart of the operation will costs big bucks. Price target of $20's have a better chance to be reached in several months.... not several years.
GLTA! and GLTA Big Pharmas out there..... the nightmares will not begin till probably after you see some Bavi data up close and personal.
News 
Market Data 
Discover 
AI
